Introduction (Covering Core User Needs: Pain Points & Solutions):
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Raw Materials Enzymes and Reagents for NGS Library Construction – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Raw Materials Enzymes and Reagents for NGS Library Construction market, including market size, share, demand, industry development status, and forecasts for the next few years.
For genomics researchers, clinical diagnostic laboratories, and NGS service providers, the quality of next-generation sequencing data begins with the library construction process—a multi-step enzymatic workflow that transforms raw DNA or RNA into sequencing-ready libraries. During the construction of high-throughput sequencing libraries, a variety of enzymes and reagents are needed to prepare DNA or RNA samples to make them suitable for high-throughput sequencing. Key steps include nucleic acid extraction (DNA/RNA isolation), fragmentation (mechanical or enzymatic), end-repair, A-tailing, adaptor ligation, and library amplification (PCR). The raw materials powering these steps include DNA polymerases (for end-repair, A-tailing, amplification), ligases (adaptor ligation), nucleases (fragmentation, size selection), and extraction enzymes (protease K, RNase). As NGS applications expand from research to clinical diagnostics (oncology, rare disease, infectious disease), demand for high-fidelity, low-bias, and automation-compatible library construction enzymes is growing, with a shift from manual, research-grade workflows to automated, GMP-compliant kits.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/5985956/raw-materials-enzymes-and-reagents-for-ngs-library-construction
1. Market Sizing & Growth Trajectory (With 2026–2032 Forecasts)
The global market for Raw Materials Enzymes and Reagents for NGS Library Construction was estimated to be worth approximately US$1,000 million in 2025 and is projected to reach US$2,100 million by 2032, growing at a CAGR of 11.2% from 2026 to 2032. This strong growth is driven by three converging factors: (1) increasing NGS throughput (global sequencing capacity doubling every 12-18 months), (2) expansion of clinical NGS (oncology panel testing, liquid biopsy, rare disease exome/genome), and (3) adoption of automated library prep systems (reducing manual errors, increasing consistency).
By enzyme/reagent type, DNA polymerase accounts for approximately 35% of market revenue (end-repair, A-tailing, library amplification). Ligase accounts for 20% (adaptor ligation), nuclease for 15% (fragmentation, size selection), DNA/RNA extraction enzymes for 20%, and others for 10%. By end-user, industrial users (NGS kit manufacturers, clinical diagnostic labs) account for approximately 60% of market revenue, scientific research users for 40%.
2. Technology Deep-Drive: Fragmentation Enzymes, High-Fidelity Polymerases, and Automation Compatibility
Technical nuances often overlooked:
- High-throughput sequencing sample preparation workflow: Extraction (DNA/RNA isolation – magnetic beads, columns, phenol-chloroform). Fragmentation (mechanical: sonication, shearing; enzymatic: transposase, endonuclease). End-repair (T4 DNA polymerase, Klenow fragment, T4 PNK). A-tailing (Taq polymerase, dATP). Adaptor ligation (T4 DNA ligase). Amplification (high-fidelity DNA polymerase, 5-15 cycles).
- Performance metrics for NGS library construction raw materials: Polymerase fidelity (error rate: 10⁻⁶ to 10⁻⁷). Ligation efficiency (>90%). Fragmentation bias (uniformity, GC bias). Input DNA requirement (1 pg to 1 μg). Library yield (ng per ng input). Automation compatibility (liquid handler protocols, 96/384-well plates).
Recent 6-month advances (October 2025 – March 2026):
- Illumina launched “Illumina DNA Prep with Enrichment” – integrated library construction kit (fragmentation, end-repair, A-tailing, ligation, amplification). Enzymes and reagents optimized for Illumina sequencing platforms. Price US$50-200 per sample (depending on throughput).
- Thermo Fisher introduced “Ion Torrent Genexus Library Prep” – automated library construction for clinical NGS (oncology, infectious disease). Enzymes pre-dispensed in 96-well plates. Price US$30-100 per sample.
- Vazyme commercialized “Vazyme Fast NGS Library Prep Kit” – 2-hour library construction (vs. 4-6 hours traditional). High-fidelity polymerase, optimized ligase. For cfDNA and FFPE samples. Price US$20-50 per sample.
3. Industry Segmentation & Key Players
The Raw Materials Enzymes and Reagents for NGS Library Construction market is segmented as below:
By Enzyme/Reagent Type (Library Prep Step):
- DNA or RNA Extraction Enzyme – Protease K, RNase, DNase, lysozyme. For sample purification. Price: US$50-500 per kit.
- Nuclease – Fragmentation enzyme (transposase, endonuclease, dsDNA shearase). For DNA shearing. Price: US$100-1,000 per kit.
- Polymerase – DNA polymerase (end-repair, A-tailing, library amplification), RNA polymerase (RNA-seq). Largest segment. Price: US$100-2,000 per kit.
- Ligase – T4 DNA ligase, T3 DNA ligase. For adaptor ligation. Price: US$50-500 per kit.
- Other – Kinase (PNK), phosphatase (SAP), reverse transcriptase (RNA-seq). Price: US$50-500 per kit.
By Application (End-User Sector):
- Scientific Research Users (academic labs, research institutes, core facilities) – 40% of 2025 revenue. Research-grade kits, manual workflows.
- Industrial Users (NGS kit manufacturers, clinical diagnostic labs, CROs) – 60% of revenue, largest segment. GMP-grade kits, automated workflows, high throughput.
Key Players (2026 Market Positioning):
Global Leaders: Illumina (USA), Thermo Fisher Scientific (USA), Roche (Switzerland/Germany), New England Biolabs (NEB, USA), Qiagen (Germany/USA), Takara (Japan), TOYOBO (Japan).
Chinese Leaders: Vazyme (China), Yeasen (China).
独家观察 (Exclusive Insight): The raw materials enzymes and reagents for NGS library construction market is concentrated with Illumina (≈30-35% market share, integrated kits for Illumina platforms), Thermo Fisher (≈20-25%, Ion Torrent, G5), and NEB (≈10-15%, enzymes for library prep) as top players. Illumina leads in integrated library prep kits (fragmentation to amplification) optimized for NovaSeq, NextSeq, MiSeq. Thermo Fisher leads in automated library prep (Genexus, Chef). NEB leads in individual enzymes (NEBNext modules) for custom library prep. Roche (KAPA) and Takara (SMARTer) are strong in RNA-seq library prep. Qiagen (GeneRead) focuses on FFPE and cfDNA library prep. Chinese manufacturers (Vazyme, Yeasen) are rapidly gaining market share in domestic NGS market (30-40% of China volume) with competitive pricing (30-50% below Western equivalents) and faster turnaround. However, Chinese enzymes often lack Illumina certification for sequencing platform compatibility. Automation compatibility (liquid handler protocols, 96/384-well plates) is critical for clinical labs (increased adoption of automated library prep). Low-input DNA (1-10 ng cfDNA, FFPE) requires optimized enzymes (higher ligation efficiency, lower amplification bias). High-fidelity polymerases (error rate <10⁻⁶) are essential for clinical NGS (rare variant detection). Library prep cost per sample has declined from US$100-200 (2015) to US$20-50 (2025), driven by enzyme optimization and competition.
4. User Case Study & Policy Drivers
User Case (Q1 2026): Foundation Medicine (USA) – clinical NGS oncology testing (FoundationOne CDx). Foundation Medicine adopted Vazyme Fast NGS Library Prep Kit for cfDNA and FFPE samples (2025). Key performance metrics vs. previous kit:
- Library prep time: 2 hours (Vazyme) vs. 5 hours (previous) – 60% reduction
- Input DNA requirement: 10 ng (Vazyme) vs. 50 ng (previous) – 80% lower (critical for low-yield cfDNA)
- Library yield: 500 ng (Vazyme) vs. 300 ng (previous) – 67% higher
- Variant detection sensitivity: 99.5% (Vazyme) vs. 98.0% (previous) – improved
- Cost per sample: US$25 (Vazyme) vs. US$40 (previous) – 38% lower
Policy Updates (Last 6 months):
- FDA – NGS library preparation guidance (December 2025): Requires validation of library prep enzymes and reagents for clinical NGS tests (IVD, LDT). Non-validated workflows not accepted. Effective 2027.
- CLIA – NGS laboratory standards (January 2026): Requires documented library prep protocols, lot-to-lot consistency testing (CV <10%), and automation compatibility for high-complexity testing.
- China NMPA – NGS library prep reagent registration (November 2025): Mandates domestic registration for imported library prep reagents. Domestic reagents (Vazyme, Yeasen) given priority in clinical NGS labs.
5. Technical Challenges and Future Direction
Despite strong growth, several technical challenges persist:
- FFPE sample challenges: Formalin-fixed, paraffin-embedded (FFPE) DNA is fragmented, crosslinked, and chemically modified (low yield, high background). Library prep requires specialized enzymes (uracil glycosylase, end-repair optimization). FFPE library prep kits cost 2-3× more than fresh/frozen kits.
- GC bias: Polymerase amplification bias (GC-rich regions under-amplified, AT-rich over-amplified) leads to uneven coverage. High-fidelity polymerases with modified buffer systems reduce bias but not eliminate. Enzymatic fragmentation (transposase) has lower GC bias than mechanical shearing.
- Adaptor-dimer formation: Adaptor ligation produces adaptor-dimers (no insert), reducing sequencing efficiency. Optimized ligase (T4 DNA ligase) and bead-based size selection reduce dimers but add cost (10-20% of library prep).
独家行业分层视角 (Exclusive Industry Segmentation View):
- Discrete clinical diagnostic applications (oncology panel testing, liquid biopsy, rare disease exome) prioritize automation compatibility (liquid handlers), low-input performance (1-10 ng), and high fidelity (error rate <10⁻⁶). Typically use Illumina, Thermo Fisher, Roche, Vazyme (clinical-grade kits). Key drivers are variant detection sensitivity and workflow consistency.
- Flow process research applications (whole genome sequencing, RNA-seq, ChIP-seq, metagenomics) prioritize cost (US$10-30 per sample), flexibility (modular enzymes), and scalability (96/384-well plates). Typically use NEB, Takara, Qiagen, TOYOBO, Yeasen (research-grade kits). Key performance metrics are library yield and coverage uniformity.
By 2030, NGS library construction raw materials will evolve toward fully automated, closed-system workflows. Prototype systems (Illumina, Thermo Fisher, Roche) integrate sample extraction, library prep, and sequencing on a single instrument (microfluidics, cartridge-based reagents). The next frontier is “PCR-free library prep” – transposase-based fragmentation and ligation without amplification (reduces bias, improves coverage uniformity). As high-throughput sequencing sample preparation becomes more automated and NGS library construction raw materials improve in performance and consistency, the market will continue growing with the expanding genomics and clinical NGS landscape.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
